Page 91 - MemoriaESP-Eng

www.ciberesp.es

ASSESSMENT OF THE SOCIAL IMPACT OF CLINICAL AND HEALTH SERVICES RESEARCH

Ex-post assessment of extramural research (projects, groups, centres, programs or
plans), ie, research return to society by:

• The impact or return (primary, secondary and final) of the research carried out in a

given area.
• Investment and outcomes (knowledge, publications, patent, applications, training of hu-

man resources, benefits for clinical practice and for health) of research in health sciences.

• r l, l Ar, l-A s, A J. Parent-child agreement on health-related quality
Most relevant AJMilópezópezguilÀlonso
of life (HRQOL): a longitudinal study.Health Qual Life Outcomes. 2013 Jun 20;11(1):101.
scientific
• Serra-Sutton V, Serrano CB, Carreras ME. Quality indicators to assess a colorectal cancer
articles
prevention program.Int J Technol Assess Health Care. 2013 Apr;29(2):166-73.

• Solans-Domènech M, Adam P, Guillamón I, Permanyer-Miralda G, Pons JM, Escarrabill J. é

Impact of clinical and health services research projects on decision-making: a qualitative
study.Health Res Policy Syst. 2013 May 10;11:15.

• teb corDoMí c, Del río lM, Di gregorio s, cAsAs l, estrADA MD, KotzeVA A. Validation of the
FRAX predictive model for major osteoporotic fracture in a historical cohort of Spanish è

women.J Clin Densitom. 2013 Apr-Jun;16(2):231-7.

• solAns-DoMnecH M, ADAM p, tebé c, espAllArgues M. Developing a universal tool for the priori-
tization of patients waiting for elective surgery.Health Policy. 2013 Nov;113(1-2):118-26.

Highlights
Group 15 has relevant national and international projects related to the assessment of
health (and eHealth) technology, healthcare quality and social impact research. Specifically

in: a) Comparative effectiveness research in health care models for patients with chronic
diseases with special emphasis on integrated care, alternatives to hospitalization and tele-

medicine/mHealth; b) Analyses of medical practice variations in healthcare procedures and
interventions; c) Healthcare registries and risk-adjustment analysis for interventions effec-

tiveness; d) Translation of evidence into clinical practice guidelines with development of
recommendations, algorithms and indicators for implementation assessment; e) Predictive

models for risk-stratification for specific conditions; and f) Development and validation of
patient reported outcomes and patient classification systems. Also, Group 15 is leading di-
verse projects related to health information and knowledge about the health care system to

contribute to improve transparency and accountability on the results of the health system.

Along 2013 Group 15 has participated in more than 10 public-competitive research projects
in these areas of expertise (8 at international level), in the majority of them being either IP

of the project or of one WP. European projects:

- DECIPHER: First European PCP project in the area of mHealth (Role: coordinator and lea-
der of the Evaluation WP)

- EpSOS (Role: leader of the Evaluation WP)

- Renewing Health (Role: leader of the evaluation of the pilot in Catalonia) 13
20
- United4Health (Role: task leader of the Evaluation WP) T
- INSPIRE (Role: leader of the Dissemination WP) OR
P
- ENIGMA (Role: leader of PCP Deliverables Guidance, Monitoring and Evaluation) RE
L
- PEGASO (Role: leader of the overall system trial definition and analysis of results WP) A
NU
- DAYSAFE (Role: collaborating partner in 3 WP)
N
A
During the same period, researchers have published more than 50 papers in international P /
and national peer-reviewed journals and elaborated numerous transfer products, including S
RE
clinical practice guidelines, evaluation and policy reports, white papers, web-based obser- E
vatories, clinical indicators and decision-aids tools.
IB
C

91